We use cookies to improve your browsing experience on our website.
Please visit our Privacy Notice for more information about cookies and how we use them. We recommend that you accept the use of cookies for better navigation.

GRAFTJACKET® Regenerative Tissue Matrix

Products described on this website (and associated product information), may not be available for sale in all markets as a result of local regulatory requirements. For information regarding product availability in your market, please contact your local Acelity/KCI representative here.

Thin, Fenestrated Acellular Human Dermal Matrix Designed for Single Application That Supports Regeneration of Host Tissue

GRAFTJACKET® Regenerative Tissue Matrix (RTM) provides a scaffold for the body’s repair or replacement of damaged or inadequate integumental tissue, such as diabetic foot ulcers, venous leg ulcers, pressure ulcers, or for other homologous uses of human integument. 
 
Each package of GRAFTJACKET® RTM is intended for use in one patient on a single occasion.  

GRAFTJACKET is a trademark of Wright Medical Technology, Inc. and licensed to KCI. Products processed by LifeCell Corporation for KCI. 

Specific indications, contraindications, warnings, precautions and safety information exist for KCI products and therapies. Healthcare providers should review the product User Manual, Safety Information and/or Instructions for Use prior to application.


  • Overview
  • How it Works
  • Indications & Applications
  • Evidence & Outcomes
  • Ordering

Overview

The dermal matrix that replaces missing dermis with “like-for-like” tissue that is consistent with native dermal tissue, even over exposed bone or tendon.
 
The matrix has an acellular scaffold and preserved vascular channels that enable repopulation and revascularization by host tissue.

GRAFTJACKET™ Matrix has demonstrated high clinical efficacy as shown in peer-reviewed studies in diabetic foot ulcers.

Single application, in most cases, to treat challenging wounds such as diabetic foot ulcers.

How it Works

  • OVERVIEW
  • MECHANISM OF ACTION

GRAFTJACKET® RTM is an intact acellular human dermal matrix that has been processed using a patented method designed to minimize damage to the scaffold and thereby reduce potential inflammatory response by the patient.

A Patented Processing Methodology 
 
The patented processing methodology results in an intact, acellular dermal matrix that retains natural biological components and the structural integrity of the complex, three-dimensional dermal matrix including intact vascular channels.
 
When used as directed, the body recognizes GRAFTJACKET® RTM as itself, and this positive recognition allows the body to initiate its own tissue regeneration process.
 
The newly regenerated dermal tissue achieves a cellular and vascular status consistent with mature, native dermis.

960x360-graftjacket-rtm.png

Indications & Applications

  • INDICATIONS & APPLICATIONS
Specific indications, contraindications, warnings, precautions and safety information exist for KCI products and therapies. Healthcare providers should review the product User Manual, Safety Information and/or Instructions for Use prior to application.
 
GRAFTJACKET® RTM for wounds provides a scaffold for the body’s repair or replacement of damaged or inadequate integument tissue, such as diabetic foot ulcers, venous leg ulcers, pressure ulcers, or for other homologous uses of human integument. 
 
Each package of GRAFTJACKET® RTM is intended for use in one patient on a single occasion.
 
Step-by-step instructions for the preparation of GRAFTJACKET® RTM convey its ease of use.
  • Measure and trim GRAFTJACKET® RTM to fit the defect and accommodate for wound depth
  • Ensure appropriate sizing to allow for suturing or stapling
  • Dermal side “down” / against the wound bed
     
Application Techniques:
GRAFTJACKET® RTM is applied using a simple, step-by-step process
  • Ensure that GRAFTJACKET® RTM contacts wound bed completely to enable vascular communication
  • Using skin staples or sutures, circumferentially affix the matrix to the margins of the wound
  • Steri-Strips™ are not recommended
Randomized controlled trials (RCTs) and retrospective studies support positive clinical outcomes using a single application of GRAFTJACKET® RTM to treat full-thickness lower extremity wounds

Clinical Evidence

Additional summary of evidence and outcomes.

Contact Us

TITLE The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: A prospective 16-week pilot study
View Abstract on PubMed
STUDY TYPE All levels
DATE 2006
AUTHORS Brigido, et al.
TITLE Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study
View Abstract on PubMed
STUDY TYPE All levels
DATE 2009
AUTHORS Reyzelman, et al.
To order any of the products listed below, please contact your KCI representative or call your local KCI Office. Click here to view our locations.
  • Product Codes

    PRODUCT  description
     
    FS-380x380-graftjacket-rtm4x8.jpg

    GRAFTJACKET™ Regenerative Tissue Matrix

    4cm x 4cm

     
     
     thin (0.38)
     
    1-380x380-graftjacket-rtm.jpg

    GRAFTJACKET™ Regenerative Tissue Matrix

    4cm x 8cm

     
     
     thin (0.38)
    Edit the text